NCT05194735 2025-11-10Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsAlaunos TherapeuticsPhase 1/2 Terminated8 enrolled 12 charts
NCT06690281 2025-09-11A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal MalignanciesNational Institutes of Health Clinical Center (CC)Phase 2 Withdrawn